Text size: A A A

Pneumococcal pneumonia can be serious. It may be preventable.

Pneumococcal pneumonia can be serious. It's a bacterial illness that can be contagious and is responsible for as many as 302,000 hospitalizations in the United States each year. Pneumococcal pneumonia isn't like the common cold. Its symptoms can be severe and last for weeks—or months.

Many people dismiss pneumonia as an illness that elderly or sick people get in the hospital. It's not. The reality is that most cases of pneumonia in the United States are acquired while people are going about their daily lives. And even people as young as 50 are at increased risk.

If you're 50 or older, vaccination is an option that may help you prevent getting pneumococcal pneumonia in the first place.

Understand pneumococcal pneumonia in 90 seconds.

From causes to impact to prevention options, learn more about this serious—and often misunderstood—disease.

Understand pneumococcal pneumonia in 90 seconds. Watch the video.
 

Prevnar 13® is a vaccine for use in adults 50 and over.

Delivered by injection in a single dose in adults 50 years of age and older, Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by 13 strains of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). This indication is based on immune responses elicited by Prevnar 13®. There have been no controlled trials in adults demonstrating a decrease in pneumococcal pneumonia or invasive disease after vaccination with Prevnar 13®. Prevnar 13® will not protect against disease caused by strains of Streptococcus pneumoniae not contained in the vaccine.